Protective role of reactive oxygen species in endotoxin-induced lung inflammation through modulation of IL-10 expression

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5734-5740

  Deng, Jing ^a,b   Wang, Xuerong ^a   Qian, Feng ^a   Vogel, Stephen ^a   Xiao, Lei ^a   Ranjan, Ravi ^a   Park, Hyesuk ^a   Karpurapu, Manjula ^a   Ye, Richard D ^a   Park, Gye Young ^a   Christman, John W ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PROTEIN KINASE B; PROTEIN P47; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 10;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; FETUS; IMMUNOMODULATION; LUNG EDEMA; MACROPHAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADOPTIVE TRANSFER; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; LUCIFERASES; LUNG; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NADPH OXIDASE; PNEUMONIA; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS;

EID: 84862091875     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101323     Document Type: Article

References (29)

1. Lambeth, J. D., K. H. Krause, and R. A. Clark. 2008. NOX enzymes as novel targets for drug development. Semin. Immunopathol. 30: 339-363.
2. phox-Rac1 chimera is a Quintessential NADPH oxidase activator: membrane association and functional capacity. J. Biol. Chem. 285: 25485-25499.
3. El-Benna, J., P. M. Dang, M. A. Gougerot-Pocidalo, J. C. Marie, and F. Braut-Boucher. 2009. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp. Mol. Med. 41: 217-225.
4. Rada, B., and T. L. Leto. 2008. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 15: 164-187.
5. Dinauer, M. C., and S. H. Orkin. 1992. Chronic granulomatous disease. Annu. Rev. Med. 43: 117-124.
6. Heyworth, P. G., A. R. Cross, and J. T. Curnutte. 2003. Chronic granulomatous disease. Curr. Opin. Immunol. 15: 578-584. (Pubitemid 37130200)
7. Brown, K. L., J. Bylund, K. L. MacDonald, G. X. Song-Zhao, M. R. Elliott, R. Falsafi, R. E. Hancock, and D. P. Speert. 2008. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin. Immunol. 129: 90-102.
8. Bylund, J., K. L. MacDonald, K. L. Brown, P. Mydel, L. V. Collins, R. E. Hancock, and D. P. Speert. 2007. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur. J. Immunol. 37: 1087-1096. (Pubitemid 46925344)
9. Zhang, W. J., H. Wei, and B. Frei. 2009. Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo. Free Radic. Biol. Med. 46: 791-798.
10. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765. (Pubitemid 32368050)
11. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
12. Berg, D. J., N. Davidson, R. Kühn, W. Müller, S. Menon, G. Holland, L. Thompson-Snipes, M. W. Leach, and D. Rennick. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses. J. Clin. Invest. 98: 1010-1020. (Pubitemid 26293320)
13. Blackwell, T. S., F. E. Yull, C. L. Chen, A. Venkatakrishnan, T. R. Blackwell, D. J. Hicks, L. H. Lancaster, J. W. Christman, and L. D. Kerr. 2000. Multiorgan nuclear factor kB activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit. Care Med. 162: 1095-1101.
14. phoxdeficiency impairs NF-κB activation and host defense in Pseudomonas pneumonia. J. Immunol. 172: 1801-1808.
15. Everhart, M. B., W. Han, K. S. Parman, V. V. Polosukhin, H. Zeng, R. T. Sadikot, B. Li, F. E. Yull, J. W. Christman, and T. S. Blackwell. 2005. Intratracheal administration of liposomal clodronate accelerates alveolar macrophage reconstitution following fetal liver transplantation. J. Leukoc. Biol. 77: 173-180. (Pubitemid 40315051)
16. Karpurapu, M., X. Wang, J. Deng, H. Park, L. Xiao, R. T. Sadikot, R. S. Frey, U. A. Maus, G. Y. Park, E. W. Scott, and J. W. Christman. 2011. Functional PU.1 in macrophages has a pivotal role in NF-κB activation and neutrophilic lung inflammation during endotoxemia. Blood 118: 5255-5266.
17. Divangahi, M., M. Chen, H. Gan, D. Desjardins, T. T. Hickman, D. M. Lee, S. Fortune, S. M. Behar, and H. G. Remold. 2009. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10: 899-906.
18. Koay, M. A., X. Gao, M. K. Washington, K. S. Parman, R. T. Sadikot, T. S. Blackwell, and J. W. Christman. 2002. Macrophages are necessary for maximal nuclear factor-κB activation in response to endotoxin. Am. J. Respir. Cell Mol. Biol. 26: 572-578. (Pubitemid 34315865)
19. Gao, X., P. Kouklis, N. Xu, R. D. Minshall, R. Sandoval, S. M. Vogel, and A. B. Malik. 2000. Reversibility of increased microvessel permeability in response to VE-cadherin disassembly. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L1218-L1225. (Pubitemid 32009508)
20. Dinauer, M. C., M. B. Deck, and E. R. Unanue. 1997. Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes. J. Immunol. 158: 5581-5583. (Pubitemid 127483958)
21. Shiloh, M. U., J. D. MacMicking, S. Nicholson, J. E. Brause, S. Potter, M. Marino, F. Fang, M. Dinauer, and C. Nathan. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10: 29-38. (Pubitemid 29077381)
22. Fridovich, I. 1997. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J. Biol. Chem. 272: 18515-18517. (Pubitemid 27318184)
23. Bulua, A. C., A. Simon, R. Maddipati, M. Pelletier, H. Park, K. Y. Kim, M. N. Sack, D. L. Kastner, and R. M. Siegel. 2011. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med. 208: 519-533.
24. Qureshi, M. H., A. G. Harmsen, and B. A. Garvy. 2003. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J. Immunol. 170: 1002-1009. (Pubitemid 36070555)
25. Deckert, M., S. Soltek, G. Geginat, S. Lütjen, M. Montesinos-Rongen, H. Hof, and D. Schlüter. 2001. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect. Immun. 69: 4561-4571. (Pubitemid 32574458)
26. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.
27. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226: 41-56.
28. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784. (Pubitemid 43090463)
29. Doble, B. W., and J. R. Woodgett. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116: 1175-1186. (Pubitemid 36410657)